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The neurocranium generates most of the craniofacial skeleton and consists of prechordal and postchordal
regions. Although development of the prechordal is well studied, little is known of the postchordal re-
gion. Here we characterize a signaling hierarchy necessary for postchordal neurocranial development
involving Fibroblast growth factor (Fgf) signaling for early speciﬁcation of mesodermally-derived pro-
genitor cells. The expression of hyaluron synthetase 2 (has2) in the cephalic mesoderm requires Fgf sig-
naling and Has2 function, in turn, is required for postchordal neurocranial development. While Hedge-
hog (Hh)-deﬁcient embryos also lack a postchordal neurocranium, this appears primarily due to a later
defect in chondrocyte differentiation. Inhibitor studies demonstrate that postchordal neurocranial de-
velopment requires early Fgf and later Hh signaling. Collectively, our results provide a mechanistic un-
derstanding of early postchordal neurocranial development and demonstrate a hierarchy of signaling
between Fgf and Hh in the development of this structure.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The neurocranium is an embryonic structure that generates
essential craniofacial structures including the skull vault, skull
base, and palate. The palate and skull base are connected and
demarcate the prechordal, or anterior, and postchordal, or pos-
terior, regions of the neurocranium, respectively. Extensive fate
mapping in tetrapod species demonstrate that the neural crest and
mesoderm contribute to the prechordal and postchordal neuro-
cranium, respectively (Couly et al., 1992, 1993; Crump et al., 2004;
Eberhart et al., 2006; Gross et al., 2008; Köntges and Lumsden,
1996; McBratney-Owen et al., 2008; Wada et al., 2011). Despite our
knowledge of the tissue origins of the neurocranium, mechanistic
studies of development have overwhelmingly focused on the
prechordal neurocranium, while the postchordal region has been
left largely neglected.
For proper formation, the neurocranium requires the orches-
tration of numerous signaling and morphogenetic events, and is
dependent on interactions with surrounding neural as well asInc. This is an open access article u
r Biosciences; Institute of Cell
l and Alcohol Addiction Re-
berhart).non-neural ectoderm, mesoderm, and endoderm (Alexander et al.,
2011; Kimmel et al., 2001; Marcucio et al., 2011; Noden and Trai-
nor, 2005; Richtsmeier and Flaherty, 2013). The complexity of
these interactions implicates the involvement of multiple signaling
molecules in neurocranial development. Much progress has been
made in elucidating those factors that induce craniofacial forma-
tion and patterning. These factors include many signaling path-
ways, including Shh, Fgf, Bmp, and Wnt (Alexander et al., 2011;
Marcucio, 2005; Richtsmeier et al., 2013; Wada et al., 2005; Wil-
son and Tucker, 2004). No one single factor can direct craniofacial
formation; instead, they interact in spatial and temporal hier-
archies that coordinate craniofacial growth and development.
While we know of many of the signaling hierarchies in the
neural-crest derived-portions of the craniofacial skeleton, little is
known of the mesoderm-derived portions. Hosokawa and collea-
gues showed that development of the posterior skull vault, a
mesoderm-derived structure, involves a signaling hierarchy be-
tween TGF-B and Msx2 (Hosokawa et al., 2007). In mouse, chick,
and zebraﬁsh, Shh is a critical midline signal necessary for chon-
drocyte differentiation in the postchordal neurocranium, as well as
other regions of the skull (Balczerski et al., 2012a; Eberhart et al.,
2006; Wada et al., 2005). Speciﬁcation of the early cephalic me-
soderm, however, is refractory to sonic hedgehog signaling (Balc-
zerski et al., 2012a), suggesting that other signals are necessary fornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the postchordal neurocranium and their importance in numerous
aspects of craniofacial development, the Fibroblast growth factor
(Fgf) family is a prime candidate for this function.
Fgfs are part of a large family of intercellular signaling mole-
cules (Itoh, 2007) that emanate from multiple tissue sources in the
head. They are also crucial in numerous aspects of craniofacial
development, including the proper migration, survival, and pat-
terning of the neural crest (Creuzet et al., 2004; Crump et al., 2006;
Hu et al., 2009; Wilson and Tucker, 2004) as well as cranial suture
formation (Nie et al., 2006; Rice et al., 2000). Furthermore, Fgfs are
implicated in a number of congenital craniofacial disorders with
reported skull base defects including Apert and Crouzon syndrome
(Aggarwal et al., 2006; Tokumaru et al., 1996). However, the role
that Fgfs play in early postchordal neurocranial development is
unknown.
Here, we characterize a signaling hierarchy required for proper
postchordal neurocranial development involving Fgf and Shh sig-
naling. Loss of function of both fgf3 and fgf8a lead to a striking loss
of the postchordal neurocranium that can be rescued by restoring
Fgf3 and Fgf8a signaling centers in the brain and mesoderm. We
go on to precisely describe, for the ﬁrst time, the dual tissue ori-
gins of the zebraﬁsh neurocranium. The zebraﬁsh postchordal
neurocranium has small pockets of neural crest-derived areas
occurring in a mostly mesodermally-derived structure. In situ
analysis reveals that both the early cephalic mesoderm marker
hyaluron synthetase 2 (has2) and markers for chondrocytes are lost
in fgf3; fgf8a knockdown embryos, and that has2 is required for
postchordal neurocranial development in an Fgf-dependent
manner. Examination of Hh loss-of-function embryos reveals that
Hh signaling is mostly dispensable for speciﬁcation of head me-
soderm. These results provide evidence of an early signalingFig. 1. The postchordal neurocranium requires Fgf signaling. (A-E) Wholemounted zebraﬁ
is to the left. (A) Wildtype, showing the prechordal versus postchordal regions of the
embryos display normal neurocrania. (D) Variable neurocranial defects occur in 63% (n¼
in fgf8a /; fgf3 / embryos is almost completely absent in 83% (n¼5/6) of embryos, in
lateral commissures (arrowhead). abc-anterior basicapsular commissure, lc-lateral comm
parachordals, prech.¼prechordal neurocranium, postch.¼postchordal neurocranium. Scinteraction required for proper postchordal neurocranial
development.2. Results
2.1. The postchordal neurocranium requires fgf8a and fgf3
The neurocranium can be split into anterior and posterior
halves (dashed line in Fig. 1A). While much research has been
directed at the development of the neural crest-derived pre-
chordal neurocranium (Fig. 1A, prech.), little is known of the de-
velopment of the postchordal neurocranium (Fig. 1A, postch.). The
postchordal neurocranium includes the parachordal cartilages
(pc), which abut the notochord (n); as well as the anterior and
posterior basicapsular commissures (abc and pbc, respectively)
which encircle the developing ear, the lateral commissures (lc),
and the occipital arches (oc) (Fig. 1A; de Beer, 1937). Due to its
development adjacent to the notochord and the hindbrain, we
reasoned that signals from one or both of these structures could
inﬂuence posterior neurocranial development.
Fgf8 and Fgf3 signal cooperatively to pattern the hindbrain,
making these two Fgfs prime candidates for our analyses. We used
a combination of genetic and morpholino-based loss of function of
these Fgf ligands, each of which resulted in similar phenotypes
(Fig. 1, Supplemental Fig. S1). Whereas neither fgf8a nor fgf3 sin-
gle-mutants show any profound postchordal neurocranial defects
(Fig. 1B and C compared to Fig. 1A), the vast majority of the
postchordal neurocranium is absent in double fgf8a;fgf3 mutants
(Fig.1E, arrowhead), with only the prechordal neurocranium and
occipital arches remaining. Furthermore, even the loss of a single
allele of fgf3 in an fgf8a mutant background gives rise to variablesh neurocrania with the viscerocrania removed at 5 days post-fertilization. Anterior
neurocranium demarcated by a dashed line, (B) fgf8a mutant, (C) and fgf3 mutant
5/8) of fgf8a /; fgf3þ / embryos (arrowheads). (E) The postchordal neurocranium
cluding the parachordals, anterior and posterior basicapsular commissure and the
issure, n-notochord, oc-occipital arch, pbc-posterior basicapsular commissure, pc-
ale bar¼20 mm.
Fig. 2. The mesoderm and neural ectoderm are Fgf sources required for postchordal neurocranial formation (A–E, A’–E’) 24 h post-fertilization confocal images of trans-
planted wildtype tissues into fgf3;fgf8 morpholino-injected hosts with and without DIC, respectively; (A”–E”) corresponding 4 days post-fertilization (dpf) neurocranial
wholemounts with viscerocrania removed. Transplanted side of neurocrania is marked with a T, and control side with a C. (F and G) 4 dpf postchordal neurocrania of
uninjected and fgf3;fgf8 morpholino injected,embryos respectively. Anterior is to the left. (A, A’ and A”) Endoderm transplants, (B, B’ and B”) otic placode transplants, (C, C’
and C”) mesoderm only, (D, D’ and D”) neural ectoderm only, and (E, E’ and E”) mesoderm and neural ectoderm double-transplants. Endoderm and otic placode transplants
fail to rescue the posterior neurocranium (compare A” and B” to F and G, n¼0/12 for endoderm and n¼0/9 for otic placode). Transplantation of mesoderm or neural
ectoderm alone partially rescues the postchordal neurocranium (compare C” and D” to F and G, n¼4/7 for mesoderm and n¼8/16 for neural ectoderm). Transplantation of
mesoderm and neural ectoderm together can fully rescue the postchordal neurocranium on the side of the embryo receiving the transplant (compare E” to F and G, n¼4/12
for full rescue and n¼4/12 for partial rescue). Quantiﬁcation of partial or full rescue is shown in graph H. scale bars¼100 mm in A–E and scale bar¼20 mm in A”.
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Fig. 3. The zebraﬁsh postchordal neurocranium is derived from both mesoderm and neural crest tissues. (A–F) Confocal images of 5 days post-fertilization ﬂatmounted
zebraﬁsh neurocrania of (A and B) sox10:KikGR, (C and D) sox10:Cre;ubiRSG, and (E and F) drl:CreERT2;ubi:switch. Anterior is to the left. In C and D the red and green channels
have been switched for clarity in comparisons to A and B. (B, D and F) Lineage-traced cells only, neurocrania outlined in white. (A–D) Neural crest contributes to the
prechordal elements the ethmoid plate and trabeculae, as well as the lateral and anterior regions of the anterior basicapsular commissures and the lateral auditory capsules.
(E and F) Mesoderm contributes the parachordals, anterior and posterior basicapsular commissure, the occipital arch, and the lateral commissures. Schematic of results
shown in G (nZ10 for each transgenic line). abc-anterior basicapsular commissure, ac-auditory capsule, ep-ethmoid plate, lc-lateral commissure, n-notochord, oc-occipital
arch, pbc-posterior basicapsular commissure, pc-parachordals, tr-trabeculae. scale bar¼50 mm.
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and parachordal cartilage loss (Fig. 1D, arrowheads). These mu-
tants also have severe viscerocranial defects (not shown, Crump
et al., 2004). Because, at least, fgf8a is maternally expressed (Re-
ifers et al., 1998), we extended our analyses using the well-char-
acterized morpholinos against each of these Fgfs (Crump et al.,
2004; Liu et al., 2003; Maves et al., 2002).
Morpholinos targeting either fgf8a or fgf3 injected into fgf3 or
fgf8amutants, respectively, recapitulated postchordal neurocranial
defects observed in the double mutants (Supplemental Fig. S1).
Embryos injected with fgf3 morpholinos display infrequent loss of
the anterior basicapsular commissure (24%, n¼6/24, Supplemental
Fig. S1), however the remainder of the neurocranium in these
embryos is well developed. Embryos injected with fgf3 morpho-
linos also consistently have fused otoliths (Supplemental Fig. S1)
as well as variable viscerocranial defects, including fusions of
Meckel's cartilage and the palatoquadrate, and loss of the cerato-
branchial cartilages (data not shown; Crump et al., 2004). As in our
mutant analysis, we found strong synergy between fgf8a and fgf3
in development of the postchordal neurocranium.
In contrast to phenotypes in single mutants, the postchordal
neurocranium is lost in fgf3 morpholino-injected fgf8a mutants
(100%, n¼21/21, Supplemental Fig. S1). The ethmoid plate and
trabeculae are retained, albeit reduced, in these embryos (n¼21/
21). Viscerocranial defects also occur in these embryos, including
variable hyosymplectic loss, severe reductions and fusions of
Meckel's cartilage and the palatoquadrate (data not shown; Crump
et al., 2004). Lastly, we recapitulated the postchordal neurocranial
loss in fgf8a morpholino-injected fgf3 mutants (Supplemental Fig.
S1). Together, these data show fgf3 and fgf8a synergize during
postchordal neurocranial development.
2.2. The mesoderm and neural ectoderm are Fgf sources required for
postchordal neurocranium formation
Fgf signaling is required throughout development, forming nu-
merous centers of activity including the mesoderm and neural ec-
toderm early, and the endoderm and otic placode later (Crump et al.,
2004; Sivak et al., 2005; Thisse and Thisse, 2005). To investigate the
required Fgf signaling source for postchordal formation, we gener-
ated genetic chimeras to re-introduce Fgf signaling from wild-type
donor tissues in fgf3;fgf8 knockdown hosts. We tested four tissue
sources: the mesoderm, neural ectoderm, endoderm, and otic pla-
code (Fig. 2, Supplemental Fig. S2). While neither endoderm nor otic
placode transplants restored the neurocranium (n¼0/12 for en-
doderm, n¼0/9 for otic placode, Fig. 2A–A” and B–B”), we observed a
partial rescue of the postchordal neurocranium in embryos receiving
either mesoderm or neural ectoderm transplants (n¼4/7 for meso-
derm, n¼8/16 for neural ectoderm, Fig. 2C–C”, D–D” and H). In these
transplants most of the parachordal cartilage and anterior basicap-
sular commissure were present, but rescue was incomplete, sug-
gesting that both tissues might be required. To test this dual re-
quirement, double mesoderm and neural ectoderm transplants were
performed, and indeed, complete rescue of the postchordal neuro-
crania on the transplanted side in fgf3;fgf8a loss-of-function hosts
was attained (n¼4/12 for full rescue, n¼3/12 for partial rescue,
Figs. 2E–E”, 2H). Together, these data suggest that Fgf signaling from
the mesoderm and neural ectoderm cooperate during formation of
the postchordal neurocranium.
Fgf signaling from the neural ectoderm induces the otic placode
(LÈger and Brand, 2002; Sai and Ladher, 2015). Thus, the partial
rescue by neural ectoderm could be indirect, due to a signal re-
layed from the placode. If this indirect signaling were responsible
for the rescue, then loss of the otic placode should phenocopy
fgf8a;fgf3 double loss-of-function embryos. The otic placode is lost
in embryos co-injected, but not singly injected, with dlx3b andfoxi1 morpholinos (Solomon et al., 2002,, 2003). We found that, as
expected, injection of both dlx3b and foxi1 caused complete loss of
the otic placode at 24 hpf (Solomon et al., 2004; Supplemental Fig.
S3). However, in these embryos only the anterior basicapsular
commissure was missing or reduced (Supplemental Fig. S3). In
fact, the parachordal cartilages may be expanded. Thus, the otic
placode may provide signals regulating postchordal neurocranial
development, and future experiments analyzing single versus
double loss-of-function embryos would help characterize this role.
However, defects to the otic placode itself do not explain the ex-
tensive loss of the postchordal neurocranium found in fgf3;fgf8
loss-of-function embryos.
2.3. The postchordal neurocranium is primarily mesoderm-derived
Deeper analysis of the role of Fgf signaling in postchordal de-
velopment requires a detailed characterization of the precursors to
this structure. However, the origins of the postchordal neurocra-
nium are unknown in zebraﬁsh. To fully characterize any neural
crest contribution to the postchordal neurocranium, we utilized
three neural-crest labeling transgenic lines, sox10:KikGR, sox10:
Kaede, and sox10:Cre;ubi:RSG (Balczerski et al., 2012b; Dougherty
et al., 2013; Kague et al., 2012). The sox10:KikGR and sox10:Kaede
embryos were photoconverted at 24 hpf when only neural crest
cells express the transgene (Balczerski et al., 2012b; Dougherty
et al., 2013), while the sox10:Cre;ubi:RSG line genetically labels
neural crest cell descendants using a promoter active in neural
crest cells (Kague et al., 2012). Results in all 3 lines were identical,
with extensive labeling in the ethmoid plate (ep) and trabeculae
(tr) of the prechordal neurocranium (Fig. 3A–D and G, data not
shown; Eberhart et al., 2006; Kague et al., 2012; Wada et al., 2005).
We also observed highly localized labeling within postchordal
structures. Labeled areas included the lateral auditory capsule as
well as the lateral and anterior-most region of the anterior basi-
capsular commissure (Figs. 3A-D, 3G). It is of interest that this
precise region articulates with the second arch crest-derived
hyosympletic of the viscerocranium (Crump et al., 2004).
The ﬁrst and second arches undergo dynamic morphogenetic
movements that involve numerous neural crest-speciﬁc cellular
rearrangements (Crump et al., 2004, 2006; Eberhart et al., 2006).
To elucidate which pharyngeal arch contributes neural crest cells
to the postchordal neurocranium, we performed fate mapping
with sox10:Kaede embryos. We photoconverted either the ﬁrst or
second arch at 26 hpf (Supplemental Fig. S4; Crump et al., 2006),
and found that the second arch crest contributed to the lateral
auditory capsule (Supplemental Fig. S4), while the ﬁrst arch crest
contributed to the lateral and anterior most region of the anterior
basicapsular commissure (Supplemental Fig. S4). Together, these
results show that neural crest of the ﬁrst and second arch con-
tribute to adjacent regions of the postchordal neurocranium.
In both mouse and chicken, mesoderm contributes signiﬁcantly
to the posterior neurocranium. We used the mesoderm-labeling
drl:CreERT2;ubi:switch line to track mesoderm derivatives in zeb-
raﬁsh (Supplemental Fig. S5; Mosimann et al., 2011). Tamoxifen
was added from 6 hpf to 24 hpf to induce Cre- excision. We ﬁnd a
pattern of labeling perfectly complimentary to that generated by
the neural crest (Fig. 3E–G). The parachordal cartilages, posterior
basicapsular commissures, and occipital arches appear to be
completely of mesoderm origin (Fig. 3E–G). The regions of the
anterior basicapsular commissure that were not labeled by neural
crest are also of mesoderm origin (Fig. 3E–G). The lateral com-
missure was the only structure where neural crest and mesoderm
cells appear to mix (Fig. 3). Collectively, these data provide a high-
resolution fate map of neural crest and mesoderm contribution to
the neurocranium and suggest that, even in regions of dual origin,
there is little mixing between these cell types.
Fig. 4. The anterior/posterior organization of postchordal cells is set by 24 h post-fertilization (hpf). (A–C) Confocal images of a Kaede-injected embryo at (A) 24 hpf and (B
and C) 4 days post fertilization (dpf). Anterior is to the left. (A) At 24 hpf Kaede was photoconverted, shown in red (the remaining green Kaede is not evident due to the
intense green ﬂuorescence from the ﬂi1:EGFP transgene), and (B) at 4 dpf, this same embryo shows labeling in the postchordal neurocranium (inset shows relative position in
the neurocranium of magniﬁed view). (C) Red channel only, the neurocrania is outlined in white. (D) Schematic of panel C, with red cells depicting the photoconverted
region. (E and E’) Graphical representation of Kaede-mediated fate mapping at 24 hpf and 4 dpf. Inset in E’ shows relative position of magniﬁed neurocrania. Question mark
denotes a region that remained unlabeled in our analyses. ac- auditory capsule, o.c.-otic capsule. Scale bars¼10 mm in A and 20 mm in C.
Fig. 5. Cartilage and pre-cartilage markers col2a1a and sox9a are absent at 24 h post-fertilization (hpf) in fgf3;fgf8a knockdown embryos. (A–H) Images of 24 hpf embryos
labeled with (A–D) col2a1a and (E–H) sox9a riboprobe. Dorsal view with anterior to the left, arrowhead denotes the anterior limit of the notochord. (A and E) Wildtype, (B
and F) fgf8a mutant, and (C and G) fgf3 morpholino embryos display normal expression of both col2a1a and sox9a. However, (D and H) fgf3 morpholino-injected fgf8a
mutants lose the expression of both col2a1a and sox9a (asterisk). scale bar¼20 mm.
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lation in Fgf loss-of-function embryos, it is necessary to understand
their location in the early embryo. We used Kaede photoconversion
to label and track groups of cells from 24 hpf to 4 days post-fertilization (dpf), when the postchordal neurocranium is well
formed in zebraﬁsh (Fig. 4A–D). We injected ﬂi1:EGFP embryos,
which labels neural crest early in development but all cartilage la-
ter, with Kaede mRNA and photoconverted cells just dorsal to the
Fig. 6. Kaede photoconverted endomesoderm postchordal-progenitor cells migrate appropriately in fgf3;fgf8a knockdown embryos. (A) Schematic of 6 h post-fertilization
(hpf) zebraﬁsh embryo showing the region of the embryo photoconverted in all subsequent experiments, dorsal to the right. (B–D) DIC confocal images showing the
photoconverted area at 6 hpf (B, magniﬁed region outlined in A), 10 hpf (C), and 4 days post-fertilization (dpf) (D). Cells have migrated adjacent to the notochord by 10 hpf
and contributed to the postchordal neurocranium at 4 dpf. At 10 hpf, cells in (E) control, (F) fgf8, (G) fgf3, and (H) fgf3;fgf8 double morpholino-injected embryos are
appropriately positioned (compared to C). scale bar¼20 mm.
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Fig. 7. Loss of has2 in Fgf knockdown embryos contributes to the postchordal neurocranial loss phenotype. (A–D, A’–D’) Images of 10 h post-fertilization, and (E–F) 24 h post-
fertilization embryos labeled with has2 riboprobe. Dorsal view and anterior to the left in all images. (G–J) Wholemounted zebraﬁsh neurocrania with the viscerocrania
removed at 5 days post fertilization. Anterior is to the left. (A’–D’) Magniﬁed areas of region outlined in (A–D). (A and A’) Uninjected wildtype, (B and B’) fgf8amutants, and (C
and C’) fgf3morpholino-injected wildtype display normal expression of has2, however, (D and D’) fgf3morpholino-injected fgf8amutants exhibit loss of expression of has2 in
the presumptive postchordal neurocrania (D and D’). (E) At 24 hpf, some has2 expression remains along the notochord, however, (F) expression is lost in fgf8a;fgf3 double
mutant embryos. Arrowheads denote end of the notochord. (G) Control morpholino-injected wildtype and (H) fgf8a mutants, as well as (I) has2 morpholino-injected
wildtypes retain the postchordal neurocranium. However, (J) has2 morpholino-injected fgf8amutants have a substantial loss of the postchordal neurocranium (arrowheads).
n¼notochord. scale bar¼50 mm in A, 10 mm in A’ and E, and 20 mm in G.
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mesoderm (Kimmel et al., 1990). In the images, the intense EGFP
ﬂuorescence masks the much dimmer green Kaede ﬂuorescence so
only the red, photoconverted, Kaede is apparent. We found that at
24 hpf, cells that contribute to the postchordal neurocranium are
positioned within the head in relative accord to their location at
4 dpf (Fig. 4E and E’, see Supplemental Fig. S6 for individual data).
Based on our analyses in Fig. 3 these cells are of mesodermal origin.
Overall, no relative change in position of these labeled cells oc-
curred between 24 hpf and 4 dpf. Cells labeled anterior of the otic
capsule (o.c.) maintain this position at 4 dpf (Fig. 4E and E’, dark
gray shade). Those cells labeled more medial and posterior to the
otic capsule at 24 hpf populate areas medial and posterior 4 dpf(Fig. 4E and E’, gray and light gray shades). During this same time
period, neural crest cells appear to undergo extensive cell re-
arrangements in forming skeletal structures (Crump et al., 2006; Le
Pabic et al., 2014). We ﬁnd little dispersion of labeled mesoderm
cells, suggesting a lack of similar rearrangements in the mesoderm-
derived skeleton. Together, these data show that the progenitors of
the postchordal neurocranium are appropriately positioned along
the anterior to posterior axis at 24 hpf.
2.4. Proper speciﬁcation of the head paraxial mesoderm requires Fgf
signaling
Our fate map of the postchordal neurocranium shows that
these cartilage precursors are in place by 24 hpf. To investigate
Fig. 8. Postchordal neurocranial development requires Fgf signaling during gastrulation. (A–D) Wholemount zebraﬁsh neurocrania, anterior is to the left. (A and B) Wildtype
neurocrania treated with DMSO or SU5402 develop normally. (C) DMSO-treated fgf8a mutants are also unaffected, however, (D) those treated with SU5402 from 6 to 10 hpf
develop severe postchordal neurocranial loss. (E) Quantiﬁcation of postchordal neurocranial defects including none (see A), ABC loss, or complete postchordal neurocranial
loss (p. nc. loss) in DMSO and SU5402 treated wildtype (fgf8aþ/þ), heterozygous (fgf8aþ/) and mutant (fgf8a/) embryos. (F–H) DMSO-treated wildtype and fgf8a
mutants and SU5402-treated wildtype express has2 appropriately; however, (I) SU5402-treated fgf8amutants display a loss of expression of has2 in postchordal neurocranial
precursors (arrowhead denotes most anterior expression). abc- anterior basicapsular commissure, lc-lateral commissure, n-notochord, oc-occipital arch, pc-parachordals,
pbc-posterior basicapsular commissure. scale bar¼20 mm in A and scale 10 mm in F.
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fgf8a, we analyzed the expression of the prechondrogenic marker
sox9a and the cartilage marker col2a1a. Compared to un-injected
and control morpholino-injected fgf8a mutants, fgf3;fgf8a double
loss-of-function embryos display a loss of col2a1a in the cephalic
mesoderm (Fig. 5D, compared to A–C, asterisks; Piotrowski and
Nusslein-Volhard, 2000). The notochord staining for col2a1a is
retained in double loss-of-function embryos, demonstrating spe-
ciﬁcity of the effect (Fig. 5D, arrowheads denote anterior no-
tochord). Furthermore, the pre-cartilage marker sox9a is also lost
in these fgf3 morpholino-injected fgf8a mutants (Fig. 5H, com-
pared to E–G). Together, these data suggest that the head paraxial
mesoderm that will generate these cartilages is either mislocalized
or improperly speciﬁed when Fgf signaling is attenuated.
To directly address if head paraxial mesoderm is mislocalized in
Fgf loss-of-function embryos, we tracked endomesoderm pro-
genitor cells from the initiation of gastrulation (6 hpf) to the end of
gastrulation (10 hpf) via Kaede photoconversion. We elaborated onestablished fate-maps of the mesoderm to label and track post-
chordal progenitor cells (Kimmel et al., 1990). We injected embryos
with Kaede mRNA, photoconverted endomesoderm cells adjacent
to the shield at 6 hpf (Fig. 6A-B), and imaged their progression
adjacent to the notochord at 10 hpf (Fig. 6C). These labeled cells
were then conﬁrmed to contribute to the postchordal neurocra-
nium at 4 dpf (Fig. 6D). Similar to control and Fgf single loss-of-
function embryos, mesoderm cells in fgf3;fgf8amorpholino-injected
embryos migrated to the notochord by 10hpf (Fig. 6H compared to
E–G). Furthermore, these cells remain adjacent to the notochord at
24 and 48 hpf (Supplemental Fig. S7). These results demonstrate
that head paraxial mesoderm does migrate to its location lateral to
the notochord in Fgf loss-of-function embryos and suggest that the
postchordal neurocranial defects may be due to a failure in speci-
ﬁcation of this population of head mesoderm cells.
Because the head paraxial mesoderm expresses sox9a and co-
l2a1a relatively early in development, we hypothesized that some
genes important in chondrocyte maturation would be early
Fig. 9. Postchordal neurocranial development does not require brachury function or a notochord. Anterior is to the left in all panels. (A–B, A’–B’) hyaluronan synthetase 2
(has2) is expressed in cephalic regions at 10 h post-fertilization (hpf) in both wildtypes and brachury mutants. (C and D) The late chondrogenic marker col2a1a at 24 hpf
appears in both brachury mutants and siblings in the forming postchordal area of the developing embryo (compare D to C, arrowhead in C denotes anterior notochord). (E
and F) At 5 days post-fertilization, postchordal neurocrania of brachurymutants are normal, sans notochord, compared to siblings (compare F to E). scale bar¼50 mm in A and
10 mm in A’ and C and 20 mm in E.
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synthetase 2 (has2) is required for hyaluronic acid synthesis (Bak-
kers et al., 2003; Moffatt et al., 2011; Necas et al., 2008; Weigel
et al., 1997; Yoshida et al., 2000). Hyaluronic acid is an importantextracellular glycosaminoglycan involved in numerous cellular
processes including chondrocyte maturation (Moffatt et al., 2011;
Necas et al., 2008). Mouse Has2 knockouts display cephalic me-
soderm defects (Camenisch et al., 2000) and in chick limb
Fig. 10. Chondrocyte differentiation is particularly sensitive to disruption of Hh signaling. All panels are anterior to the left. (A–B, A’–B’) At 10 h post-fertilization (hpf), the
early mesoderm marker has2 is expressed in the anterior region of smoothened mutants and wildtypes (Compare B to A, B’ to A’). (C and D) However, smoothened mutants
display a marked reduction in col2a1a expression in the forming postchordal neurocranium at 28 hpf compared to siblings (compare D to C, arrowhead denotes anterior
notochord). Scale bar¼50 mm in A and 10 mm in A’.
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cells, and breast cancer cells, Has2 is positively regulated by Fgf
signaling (Bohrer et al., 2014; Hamerman et al., 1986; Munaim
et al., 1991; Urness et al., 2010). These data suggest that has2might
not only be a marker of head paraxial mesoderm, but may also be
involved in the Fgf loss-of-function phenotype.
Our earlier analysis revealed that localization of the head
paraxial mesoderm was unperturbed in fgf3;fgf8 knockdown em-
bryos at 10 hpf. However, by 10 hpf, has2-positive cells abutting
the notochord in the most anterior region, where the postchordal
neurocranium is developing, are lost in fgf3;fgf8 knockdown em-
bryos (Fig. 7D–D’, compared to A–C, A’–C’). Expression of has2 at 24
hpf is also lost in double fgf8a; fgf3mutant embryos (Fig. 7E and F).
No gross alterations in earlier has2 expression, at 6 hpf, could beascertained in fgf3;fgf8 knockdown embryos (Supplemental Fig.
S8). This suggests that early cephalic mesoderm is not properly
speciﬁed when Fgf signaling is attenuated.
Chondrocyte maturation has been shown to rely on has2 func-
tion, however, it was unclear whether loss of has2 contributed di-
rectly to the postchordal neurocranial defects in fgf3;fgf8 knock-
down embryos. We injected fgf8a mutants with a suboptimal dose
of a previously published morpholino targeting has2 (Bakkers et al.,
2004). Wildtype siblings are largely unaffected in the posterior
neurocranium (Fig. 7I compared to G), as are control morpholino-
injected fgf8a mutants (Fig. 7H compared to G). However, has2
morpholino-injected fgf8a mutants display partial loss of the post-
chordal neurocranium (Fig. 7J, arrowheads). This treatment also
causes reductions to the neural crest-derived portion of the
Fig. 11. Hh signaling is required after Fgf signaling for postchordal neurocranial development. The expression of has2 is retained following either (A–A’) DMSO or (B–B’)
cyclopamine treatment from 6 to 10 h post-fertilization (hpf). (C and D and F–H) DMSO- and cyclopamine-treated embryos from 6 to 10 hpf show expression of both sox9a
and col2a1a at 24 hpf, however, (E and H) cyclopamine-treated embryos from 10 to 24 hpf show a loss of sox9a and col2a1a expression in the postchordal neurocranium at 24
hpf. Arrowheads denote the anterior limit of the notochord. scale bar¼50 mm in A and 10 mm in A’.
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neural crest (Casini et al., 2012). These data suggest that the ex-
acerbated postchordal neurocranial defects observed in fgf3; fgf8
knockdown embryos is, at least, partially due to loss of has2.
The major function of Has2 is in the synthesis of hyaluronic
acid (Bakkers et al., 2003; Moffatt et al., 2011; Necas et al., 2008;
Weigel et al., 1997; Yoshida et al., 2000), which is known to reg-
ulate cartilage development (Matsiko et al., 2012; Matsumoto
et al., 2009; Sato et al., 2014). To test the requirement of thisfunction of has2, we treated fgf8a mutants with a suboptimal
concentration of 4-methylumbelliferon (4-MU; Sigma-Aldrich),
which is known to inhibit hyaluronic acid production (García-Vilas
et al., 2013). Treating fgf8a mutants with 4-MU between 6 and 10
hpf did not result in appreciable postchordal neurocranial defects
(not shown). However, when treated between 10 and 30 hpf,
4 MU-treated fgf8a mutants display loss of col2a1a expression at
30 hpf and, at 5 dpf, disruption of mesodermal-derived portions of
the postchordal neurocranium, as compared to control-treated
Fig. 12. Cephalic mesoderm speciﬁcation and differentiation utilizes Fgf and Hh signaling pathways. (A) During early postchordal mesoderm speciﬁcation, Fgf signaling from
both the overlying neuroectoderm and mesoderm is necessary for has2 expression in mesodermal progenitors of the postchordal neurocranium. (B) During differentiation,
Hh signaling from the overlying neuroectoderm promotes the expression of sox9a and col2a1a in these mesodermal cells. (C) Loss of fgf8a and fgf3 results in a loss of has2
expression in mesodermal cells, while (D) reduced Hh signaling results in loss of proper differentiation of these cells.
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Fig. S9). Collectively, these data suggest that the postchordal
neurocranial defects found in Fgf-compromised embryos is de-
pendent on an early requirement for Fgf signaling on hyaluronic
acid production in postchordal neurocranial precursors.
Due to the loss of has2 expression at 10 hpf in fgf3;fgf8a
knockdown embryos, we reasoned that Fgf signaling would be
required early for postchordal neurocranial development. Using a
suboptimal dose of SU5402 (Tocris Biosciences) from 6 to 10 hpf
on fgf8a mutants and siblings, which only partially reduces Fgf-
dependent etv4 expression at 10 hpf in wildtype and fgf8a-treated
embryos (Supplemental Fig. S10), we found that, while SU5402-
treated wildtypes showed normal neurocranial development
(Fig. 8B compared to A and E), both heterozygote and mutant fgf8a
zebraﬁsh showed postchordal neurocranial defects, affecting the
anterior basicapsular commissure in heterozygotes, and the en-
tirety of the postchordal neurocranium in mutants (Fig. 8D com-
pared to A–C and E). Furthermore, has2 expression at 10 hpf in
SU5402-treated fgf8amutants is completely absent in the region of
the developing postchordal neurocranium (compare Fig. 8I to F
and G). Likewise, at 24 hpf, both col2a1a and sox9a are reduced in
SU5402-treated fgf8a mutants (Supplemental Fig. S11). These data
strongly suggest that Fgf signaling is required during gastrulation,
between 6 and 10 hpf, for postchordal neurocranial formation and
speciﬁcation.2.5. The notochord is dispensable in the formation of the postchordal
neurocranium
Our data show that Fgf signaling, originating from the meso-
derm and neural ectoderm, is required in the development of the
postchordal neurocranium. Previous reports have shown the im-
portance of Shh signaling from the notochord in this process
(Balczerski et al., 2012a). Considering our data, Fgf and Shh to-
gether may form a signaling hierarchy required for postchordal
neurocranial development. Thus, we investigated the function of
the notochord and Shh in the formation of the postchordal
neurocranium.
To directly ask whether the maintenance of a notochord is
necessary for cephalic mesoderm induction and postchordal
neurocranial formation, we analyzed brachyury mutants (pre-
viously known as no tail), which transfate the notochord early in
development (Amacher et al., 2002). However, brachyury mutants
express has2 at 10 hpf (Fig. 9B–B’, compared to A–A’), col2a1a at 24
hpf (Fig. 9D), and retain a postchordal neurocranium (Fig. 9F,
compared to E). These data show that notochord maintenance is
dispensable for the formation of the postchordal neurocranium.
In brachyurymutants, midline sources of Hh remain. To directly
test the involvement of Hh signaling in posterior neurocranial
development, we analyzed smo mutants, which lack all Hh sig-
naling and a postchordal neurocranium (Eberhart et al., 2006). In
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postchordal neurocranium is present (Fig. 10B–B’ compared to A–
A’), but there are severe reductions in cells expressing the chon-
drocyte marker col2a1a (Fig. 10D compared to C, Eberhart et al.,
2006; Wada et al., 2005). Our smo data suggests that Hh signaling
is required for differentiation of chondrocytes in the mesoderm-
derived postchordal neurocranium after 10 hpf.
To directly test the temporal requirement of Hh in the for-
mation of the posterior neurocranium, we utilized the pan-Hh
inhibitor cyclopamine (Toronto Research Chemicals; Hirsinger
et al., 2004). Treating wild-type embryos from 6 to 10 hpf with
cyclopamine did not abolish has2 expression at 10 hpf in the
anterior region of the embryo (Fig. 11B and B’ compared to A and
A’). In these same embryos, sox9a and col2a1a expression at 24
hpf remained as well (Fig. 11D and G compared to C and F, re-
spectively), albeit to a potentially lesser degree. However,
blocking Hh signaling between 10 and 24 hpf resulted in the
complete absence of sox9a and col2a1a expression (Fig. 11E and
H). Together, these data suggest that, while Hh signaling is es-
sential for cartilage differentiation, it plays less of a role in early
speciﬁcation of mesoderm-derived postchordal neurocranial
progenitors (Fig. 12). Fgf signaling, on the other hand, is im-
portant for this early speciﬁcation step, via activation of has 2
(Fig. 12).3. Discussion
Here we describe a hierarchy of genetic signaling required for
the speciﬁcation and differentiation of the postchordal neuro-
cranium in zebraﬁsh. The postchordal neurocranium is a struc-
ture primarily derived from mesoderm, and is lost in embryos
with attenuated Fgf or Shh signaling. Fgf signaling plays an early
role in the speciﬁcation of head mesoderm via has2. The loss of
has2 and subsequent hyaluronic acid production is at least partly
causative of the postchordal neurocranial defects. Shh signaling is
then required for the later differentiation of sox9a and col2a1a-
expressing chondrocytes in the postchordal neurocranium. To-
gether, these results reveal a previously unknown genetic sig-
naling hierarchy required in the development of the postchordal
neurocranium.
3.1. The dual origin of the zebraﬁsh neurocranium
The zebraﬁsh neurocranium originates from the neural crest
and mesoderm. Frog, mouse, and chick fate-maps show similar
neurocranial contributions (Couley et al., 1993; Gross and Hanken,
2008; Jiang et al., 2002; Kontges and Lumsden, 1996; McBratney-
Owen et al., 2008). Our results strongly suggest that the ancestral
pattern of neurocranial contribution is neural crest being largely
restricted to prechordal regions, and mesoderm only providing
contributions to postchordal regions. The prechordal neurocra-
nium is exclusively of neural-crest origin. This region of the neu-
rocranium has received a good deal of characterization in zebraﬁsh
(Eberhart et al., 2006; Kague et al., 2012; Mongera et al., 2013;
Wada et al., 2005), therefore, here we will focus on the post-
chordal neurocranium.
Using a pan-mesodermal Cre-transgenic line driven by draculin,
we found that the majority of the postchordal neurocranium is
mesoderm-derived. In mouse and chick, the postchordal neuro-
cranium is also primarily mesoderm-derived (Couly et al., 1992,
1993; Kontges and Lumsden, 1996; McBratney-Owen et al., 2008).
These data are lacking in frog, however, in neural-crest labeling
fate-map studies, non-neural crest derived cartilages are all posi-
tioned in the postchordal neurocranium (Gross and Hanken,
2008).More effort has been spent in mapping the neural crest-derived
portions of the prechordal skull (Couly et al., 1993; Gross and
Hanken, 2008; Kague et al., 2012; Kontges and Lumsden, 1996;
Jiang et al., 2002; McBratney-Owen et al., 2008). Our fate mapping
has deﬁned the precise postchordal structures that neural crest
cells contribute to in zebraﬁsh, including the most lateral regions
of the basicapsular commissures, the lateral auditory capsule, and
the parts of the lateral commissures. These areas are important for
articulations with the jaw support element the hyosymplectic, as
well as muscle attachment sites (Köntges and Lumsden, 1996).
Furthermore, ﬁrst and second arch neural crest cells contribute to
distinct regions of the postchordal neurocranium. Along with re-
sults in chick (Köntges and Lumsden, 1996), this ﬁnding suggests
an evolutionarily conserved function of neural crest in forming
attachment sites in the postchordal neurocranium with the neural
crest-derived jaw, jaw supports, and muscle attachment sites
(Köntges and Lumsden, 1996).
3.2. Fibroblast growth factor signaling in the zebraﬁsh neurocranium
The vertebrate neurocranium is the product of the mesoderm
and the cranial neural crest, yet requires interactions between
multiple tissues. An important regulator of the development of the
neural crest-derived portion of the neurocranium is Fibroblast
growth factor signaling (Creuzet et al., 2004; Crump et al., 2006;
Monsoro-Burq et al., 2003). Our data reveal a second, and much
earlier, role for Fgf signaling in the mesoderm-derived postchordal
neurocranium.
We show that loss-of-function of both fgf3 and fgf8a cause se-
vere defects in postchordal neurocranial development. The root of
this defect is likely the misspeciﬁcation of cephalic mesoderm at
the end of gastrulation. Notably there is a loss of expression of the
chondrocyte-regulator hyaluronan-synthetase 2 (has2), which is
essential for hyaluronic acid production, positioning has2 down-
stream of Fgf. In fgf8a mutants, loss of has2 or hyaluronic acid, led
to perturbed postchordal neurocranial defects similar to fgf3;fgf8
loss-of-function embryos. These data suggest that has2 is neces-
sary for proper postchordal neurocranial formation in fgf8a-de-
pendent fashion. It will be of interest to determine if transgenic
activation of has2 is sufﬁcient to rescue the Fgf loss-of-function
defects. How has2 expression is activated downstream of Fgf sig-
naling and if Fgf signals directly to the head paraxial mesoderm
remain to be elucidated. Fgf signaling could maintain has2 ex-
pression directly, via STAT3 activation (Saavalainen et al., 2005).
Indeed, Fgf receptors have been shown to activate HAS2 function
in breast cancer cells via STAT3 (Bohrer et al., 2014). Under-
standing the requirement of Fgf receptors in the postchordal
neurocranium is of ongoing interest and will be important to
understand the exact mechanism of Fgf-dependent has2 function
in the postchordal neurocranium.
3.3. A signaling hierarchy orchestrates the speciﬁcation and differ-
entiation of the postchordal neurocranium
Proper craniofacial development relies on complex hierarchies
of signaling pathways. Our analysis indicates Fgf signaling from
the mesoderm and neuroectoderm is a major regulator of post-
chordal neurocranial development. Otic placode development is
dependent upon signals from the neuroectoderm (LÈger and
Brand, 2002; Sai and Ladher, 2015), which could confound our otic
placode transplantation results. However, loss of the otic placode
itself only results in variable anterior basicapsular commissure
loss, not the severe postchordal neurocranial loss phenotype ob-
served in fgf3;fgf8 knockdown embryos. Thus, the mesoderm and
neuroectoderm appear to be the most important sources of Fgf for
postchordal development.
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postchordal neurocranial formation and that shh emanating from
this structure mediates the formation of the postchordal neuro-
cranium via chondrogenesis of the paraxial mesoderm (Balczerski
et al., 2012a). Consistent with this report, we ﬁnd a loss of differ-
entiated chondrocytes in the postchordal neurocranium. In con-
trast, has2 expression was retained, albeit potentially reduced, in
smoothened mutants, which completely lack Hh signaling (Varga
et al., 2001), and in embryos treated with cyclopamine from 6 to
10 hpf compared to controls. This shows that, unlike Fgf signaling,
Hh signaling may be dispensable in early speciﬁcation of post-
chordal neurocranium precursors, but is certainly important in
their terminal differentiation.
The notochord has been thought to be a critical source of Shh
for posterior neurocranial development (Balczerski et al., 2012a,
2012b). Analysis of brachyury mutants, which transfate the no-
tochord during gastrulation (Amacher et al., 2002; Halpern et al.,
1993), showed that the postchordal neurocranium was fully de-
veloped and included a chondrocytic region expanded into the
area where the notochord develops. The expression of shh is
maintained in brachyury mutants (Amacher et al., 2002). Collec-
tively, these ﬁndings suggest that the notochord is not a required
shh source. However, the possibility remains that, in wild-type
embryos, shh from the notochord does serve a signaling function
to the developing postchordal neurocranium.
Our ﬁndings now place Fgf signaling prior to Hh in the for-
mation of the postchordal neurocranium. Cephalic mesoderm is
ﬁrst speciﬁed in an Fgf-dependent manner beginning at 10 hpf via
activation of has2. Temporal-loss of Fgf signaling via SU5402
treatment also shows that Fgf signaling is required early, from 6 to
10 hpf, for has2 activation. Loss of has2 ultimately results in the
loss of the chondrogenic program resulting in postchordal neu-
rocranial defects in Fgf loss-of-function embryos. Shh, on the other
hand, is not essential for this early activation of has2, but supports
proper chondrogenic differentiation of this group of cells. To-
gether, these results clarify the temporal and genetic control re-
quired for proper postchordal neurocranial development in
zebraﬁsh.4. Materials and methods
4.1. Fish husbandry and care
All embryos were raised and cared for using established pro-
tocols (Westerﬁeld, 1993) with IACUC approval from the University
of Texas at Austin. The fgf8ati282a (Brand et al., 1996), fgf3t24149
(Herzog et al., 2004), brachyury b195 (Schulte-Merker et al., 1994),
smoothenedb577(Varga et al., 2001), sox10:Cre (Kague et al., 2012),
sox10:KikGR (Balczerski et al., 2012b), sox10:kaede (Dougherty
et al., 2013), ubi:switch (Mosimann et al., 2011), and ubi:RSG (Ki-
kuchi et al., 2010) alleles have all been described previously. The
drl:CreERT2 line was generated using a 3.8 kb draculin promoter
upstream of the ATG start site. Primers used to amplify this pro-
moter were: for1: ATTGCGGCCGCTTCAATTGTGGTTGAGCAGTC.
rev1:ATTACTAGTCCAAGTGTGAATTGGGATCG. The 3.8KB fragment
was ampliﬁed with iProof polymerase (BioRad), then cloned into
TOPO-Blunt (Invitrogen). After veriﬁcation, the promoter was sub
cloned into the Tol2 vector (Kawakami et al., 2004) upstream of
the CRE-ERT2 (Feil et al., 1996, PNAS). The Tol2-drl-creert2 vector
was co-injected with Tol2 mRNA into AB* in order to establish a
founder line. Tamoxifen was added from 10 to 24 h post-fertili-
zation on the drl:CreERT2 line, and the sox10:KikGR and sox10:
kaede lines were UV-activated at 24 h post-fertilization using
DAPI-ﬁlter attached to a Zeiss LSM 710. Embryos were treated in
embryo media with 5 μM SU5402 (Tocris Biosciences) from 6 to 10hpf, and 100 μM cyclopamine (Toronto Research Chemicals) or
1 mM 4-methylumbelliferone (Sigma-Aldrich) from 6 to 10 and
10–24 hpf.
4.2. Morpholino and RNA injection
Approximately 5 nl of morpholinos (Gene Tools), working
concentrations of 5 mg/ml of a combination of fgf3b and fgf3c
morpholinos with sequences 5′GGTCCCATCAAAGAAGTATCATTTG3′
and 5′TCTGCTGGAATAGAAAGAGCTGGC3′, respectively (Maves
et al., 2002), of a combination of fgf8aE212 and fgf8aE313 with
sequences 5′TAGGATGCTCTTACCATGAACGTCG3′ and 5′CACA-
TACCTTGCCAATCAGTTTCCC3′ (Draper et al., 2001), and control
morpholinos with sequence 5′CCTCTTACCTCAGTTACAATTTATA3′
were injected into one- or two-cell stage embryos of fgf8a and fgf3
lines. Approximately 3 nl of a working concentration of 3 mg/ml of
fgfr3 morpholino with sequence 5′AAATGAGGTGTAATGTCT-
GACCTGT3′ was injected into fgf8a mutants. This dose was sub-
optimal, as it did not cause any defects to wildtype-injected em-
bryos. This is a splice-blocking morpholino targeting the ﬁrst
exon-intron boundary of fgfr3. To validate the targeting of this
morpholino, whole embryo RNA extracts were isolated from un-
injected and fgfr3 morpholino-injected zebraﬁsh at 24 hpf using
Trizol extraction (Invitrogen). cDNA pools were then synthesized
using Superscript First-Strand Synthesis System (Invitrogen). To
detect changes in mRNA transcripts in morphant embryos, PCR
was performed on cDNA pools using the gene-speciﬁc primers
spanning the morpholino-targeted exon-intron boundary For-
TACAGTGCACACCTGCTGTC and revAGCCAATGGATACTGGGCG giv-
ing a ﬁnal size of 491 bp in wildtype. Other morpholinos used that
were previously described: dlx3b: 5′-ATATGTCGGTCCACT-
CATCCTTTAAT-3′ (Solomon et al., 2002); foxi1: 5′-TAATCCGCTCTCC
CTCCAGAAACAT-3′ (Solomon et al., 2003) ; and, has2, which re-
quired dual injection of two morpholinos: 5′-AGCAGCTCTTTGGA-
GATGTCCCGTT-3′ and 5′-CGTTAGTTGAACAGGGATGCTGTCC-3′
(Bakkers et al., 2004).
Kaede mRNA was injected into one-cell stage embryos, with or
without morpholinos, and UV activated at either 6 or 24 hpf using
a Zeiss LSM 710 Confocal microscope.
4.3. Cartilage and bone staining
Five and four day postfertilization (dpf) zebraﬁsh embryos
were stained with Alcian blue and Alizarin Red (Walker and
Kimmel, 2007), and then were either ﬂat mounted (Kimmel et al.,
1998) or had the viscerocrania removed for imaging. Images were
taken with a Zeiss Axio Imager-AI microscope. Graphs were made
in Microsoft Excel 2011.
4.4. Confocal microscopy and ﬁgure processing
Confocal z-stacks were collected on a Zeiss LSM 710 using Zen
software. Images were processed in Adobe Photoshop CS. Kaede
and tissue fate maps were generated in Adobe Photoshop CS by
overlaying images gathered on the Zeiss confocal. Graphs were
generated using Microsoft Excel 2011.
4.5. In situ hybridization
RNA in situ hybridization was performed as reported in Miller
et al. (2000). AB wildtype, fgf8a, fgf3;fgf8a morpholino, brachyury,
and smoothened embryos were treated with 0.0015% PTU (1-phenyl
2-thiourea) to inhibit the production of melanin (Westerﬁeld, 1993).
Probes used were sox9a (Yan et al., 2002), col2a1a (Yan et al., 1995),
and the has2 probe was generated using primers For:ACAAGT-
CACTGGCCCTATGC and Rev:GGTAGGTAATGGGCGTCTCG (NCBI ref#
N. McCarthy et al. / Developmental Biology 415 (2016) 261–277276NM_153650.2). DIC images of in situ hybridizations were collected
on a Zeiss Axioimager.
4.6. Cell transplants
Genetic mosaics were generated as described elsewhere
(Crump et al., 2004; Maves et al., 2002; Stafford et al., 2006). For
neural and otic placode tissue transplants, embryos were injected
at the 1-2 cell stage with 2.5% Rhodamine Alexa 568 dextran. At
shield stage (6 hpf), donor cells were removed and placed into
corresponding areas in fgf3;fgf8 morpholino-injected hosts using
previously described fate maps (Kimmel et al., 1990 and Woo and
Fraser, 1995). Mesoderm transplants were performed at shield
stage (4 hpf) using donor tissue cells located at the margin and
moved to the margins of fgf3;fgf8 morpholino-injected hosts
(Kimmel et al., 1990). For endoderm transplants, donor 1 cell stage
embryos were injected with a mixture of 2.5% Rhodamine Alexa
568 dextran and sox32 mRNA and donor cells located at the
margin at shield were transplanted into the margin of fgf3;fgf8
morpholino-injected hosts (Stafford et al., 2006). For double me-
soderm and neural transplants, donor tissue from 2.5% Rhodamine
Alexa 568 dextran injected hosts was transplanted at both sphere
(taking cells from the margin) and shield (taking cells from the
neural ectoderm-forming region) into fgf3;fgf8 morpholino-in-
jected hosts. At 24 hpf, all hosts were screened using a LeicaM216F
ﬂuorescence stereomicroscope for substantial and tissue-speciﬁc
contributions of donor tissue for subsequent analysis.Author contributions
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